POLIOVIRUS VACCINES AND THE CONTROL OF POLIOMYELITIS.
作者信息
STUART-HARRIS C H
出版信息
Proc R Soc Med. 1964 Jun;57(6):459-62. doi: 10.1177/003591576405700608.
Abstract
摘要
相似文献
1
POLIOVIRUS VACCINES AND THE CONTROL OF POLIOMYELITIS.脊髓灰质炎疫苗与脊髓灰质炎的防控
Proc R Soc Med. 1964 Jun;57(6):459-62. doi: 10.1177/003591576405700608.
2
THE FUTURE OF INACTIVATED POLIOMYELITIS VACCINES.灭活脊髓灰质炎疫苗的未来
Proc R Soc Med. 1964 Jun;57(6):462-4. doi: 10.1177/003591576405700609.
3
CURRENT CONCEPTS IN THE PREVENTION OF PARALYTIC POLIOMYELITIS.
Northwest Med. 1963 Sep;62:715-20.
4
[PROBLEMS CENTERING AROUND POLIOVACCINE].
Sogo Rinsho. 1964 Jul;13:1255-65.
5
POLIOMYELITIS--VIRGINIA 1963.
Va Med Mon (1918). 1964 Feb;91:72-4.
6
AN EPIDEMIOLOGICAL EVALUATION OF THE EFFECT OF THE ORAL POLIOMYELITIS VACCINE.
Jpn J Med Sci Biol. 1963 Jun;16:131.
7
SABIN POLIOMYELITIS VACCINE. PRELIMINARY REPORT-1962.
Tex State J Med. 1963 Aug;59:790-2.
8
[CONTRIBUTION TO THE STUDY OF POLIOMYELITIS ERADICATION IN THE CITY OF BUCHAREST].
Arch Roum Pathol Exp Microbiol. 1963 Sep;23:731-6.
9
[VACCINATION AGAINST POLIOMYELITIS IN BELGIUM].
Brux Med. 1964 Sep 6;44:907-11.
10
MASS IMMUNISATION AGAINST POLIOMYELITIS IN CEYLON IN 1962 USING SABIN ORAL VACCINE.1962年在锡兰使用萨宾口服疫苗进行脊髓灰质炎大规模免疫接种。
J Trop Med Hyg. 1965 May;68:105-9.
引用本文的文献
1
SURVEILLANCE OF THE SAFETY OF ORAL POLIOMYELITIS VACCINE IN ENGLAND AND WALES 1962-4.1962 - 1964年英格兰和威尔士口服脊髓灰质炎疫苗安全性监测
Br Med J. 1965 Aug 28;2(5460):504-9. doi: 10.1136/bmj.2.5460.504.
2
Polio-virus vaccines--an iota of risk?
Indian J Pediatr. 1965 Oct;32(213):335-6.
3
Paralytic poliomyelitis in Norway since the introduction of trivalent oral vaccine: an epidemiological and virological study.自三价口服脊髓灰质炎疫苗引入以来挪威的麻痹性脊髓灰质炎：一项流行病学和病毒学研究
Bull World Health Organ. 1971;45(6):733-9.
本文引用的文献
1
Clinical and serologic responses in volunteers given vacuolating virus (SV-40) by respiratory route.
Proc Soc Exp Biol Med. 1961 Oct;108:56-9. doi: 10.3181/00379727-108-26843.
2
Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine.作为口服脊髓灰质炎疫苗污染物摄入后空泡化SV - 40病毒（乳头多瘤空泡病毒组）的排泄情况。
Proc Soc Exp Biol Med. 1962 Apr;109:965-8. doi: 10.3181/00379727-109-27392.
3
The quantitation of poliomyelitis virus in the human alimentary tract with reference to coexisting levels of homologous serum neutralizing antibody.参考同源血清中和抗体共存水平对人体消化道中脊髓灰质炎病毒进行定量分析。
Am J Hyg. 1962 Jan;75:1-17. doi: 10.1093/oxfordjournals.aje.a120227.
4
THE CUTTER INCIDENT. POLIOMYELITIS FOLLOWING FORMALDEHYDE- INACTIVATED POLIOVIRUS VACCINATION IN THE UNITED STATES DURING THE SPRING OF 1955. I. BACKGROUND.卡特事件。1955年春季美国甲醛灭活脊髓灰质炎病毒疫苗接种后发生的脊髓灰质炎。一、背景。
Am J Hyg. 1963 Jul;78:16-28. doi: 10.1093/oxfordjournals.aje.a120327.
5
Induction of malignancy in vitro in newborn hamster kidney tissue infected with simian vacuolating virus (SV40).用猿猴空泡病毒（SV40）感染新生仓鼠肾组织后在体外诱发恶性肿瘤。
Proc Soc Exp Biol Med. 1962 Nov;111:323-8. doi: 10.3181/00379727-111-27780.
6
An evaluation of the carcinogenicity of simian virus 40 in man.对猿猴病毒40对人类致癌性的评估。
JAMA. 1963 Aug 31;185:713-8. doi: 10.1001/jama.1963.03060090045016.
7
The vacuolating virus, S.V. 40.空泡病毒，即猴病毒40（SV40）
Proc Soc Exp Biol Med. 1960 Nov;105:420-7. doi: 10.3181/00379727-105-26128.
8
Vacuolating agent.空泡形成剂。
Br Med J. 1961 Jul 29;2(5247):287-8. doi: 10.1136/bmj.2.5247.287.
9
Vaccination against poliomyelitis with live virus vaccines. 7. Effect of previous Salk vaccination on virus excretion.使用活病毒疫苗进行脊髓灰质炎疫苗接种。7. 先前接种索尔克疫苗对病毒排泄的影响。
Br Med J. 1961 Jul 29;2(5247):266-9. doi: 10.1136/bmj.2.5247.266.
Zotero 插件